FOLH1 and prostate carcinoma: Using a murine prostate cancer model the investigators were able to demonstrate that PSMA CAR T cell with co-expression of TGF-βRII had increased proliferation of these lymphocytes, enhanced cytokine secretion, resistance to exhaustion, long-term in vivo persistence, and the induction of tumor eradication.